Navigation Links
Translating the language of capital-raising

Virtually every area of recurring human endeavor has its own lingo. Whether it be at play (like in running, football or racing) or work (think government workers, lawyers, education, military), it seems that when a group of people get together, they develop their own language that few outside of the group can understand. The world of equity capital raising is no exc......

Full article >>> ture financing in which securities are sold at a lower price than originally paid by the holder of the right. Typically, anti-dilution provisions come in two types: full ratchet and weighted average. There are typically exceptions for the adjustment mechanism that carve out situations such as the issuance of certain employee options or existing convertible securities.

Assignment of in......

Full article >>> after a specified date or the occurrence of a certain event.

Capitalization - The combined sources of capital, consisting of debt capital (liabilities) and equity capital (capital stock and retained earnings).

Cap table - Short for capitalization table, it is a summary of a company's issued and outstanding securities.

Convertible notes - Debt instrum......

Full article >>> es are issued at a lower price than the previous round of financing.

Drag-along rights - Rights that enable a shareholder or group of shareholders (usually those who own a controlling interest in the company) to compel other shareholders to sell their stock in the event a purchaser desires to purchase more than what the controlling shareholder(s) own(s).

Exit strategy......

Full article >>> eholder's securities following a public offering.

Mezzanine financing - Typically a hybrid of debt and equity financing that is used to finance the expansion of an existing company. It is generally subordinated to debt provided by senior lenders such as banks.

No-shop requirement - A contractua......

Full article >>> offered to new investors. They are similar to participation rights.

Preferred stock - Stock that gives its holders certain rights, preferences, and privileges over holders of common stock in certain instances.

Put rights - A right that enables the investor to force the company or another investor to buy back the investor's securities, usually for a particular price......

Full article >>> e at which the additional shares were issued. Compare to full-ratchet anti-dilution protection.

Previous articles by Matt Storms

Matt Storms: Securities compliance is part of raising capital

Matt Storms: Raising capital through placement agents
Full article >>>
'"/>


Source:wistechnology.com By Matt Storms 03/25/07


Related biology technology :

1. UW language faculty create multimedia training tool
2. NimbleGen names CFO with capital-raising past
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc ... with Compass Research . GGI's mission is to advance global health and highlight ... in need in honor of each clinical trial volunteer. The vision of GGI is ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology ... for research and clinical applications. The terms of the transaction were not disclosed. ...
(Date:2/22/2017)... CINCINNATI , Feb. 22, 2017 Scientists ... drives inflammation and organ damage in Gaucher and maybe ... fewer risks and lower costs than current therapies. ... Children,s Hospital Medical Center , which also included investigators ... , report their data Feb. 22. The study ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):